Recent years have witnessed significant advances in the field of diabetes treatment, with a particular focus reta on GLP-1 receptor agonists. Among these novel therapies, retatrutide and trizepatide are emerging as promising candidates, showing exceptional results in clinical trials. Retatrut… Read More